Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension.

[1]  J. Geleijnse.  Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. , 2011, American journal of hypertension.

[2]  C. Rosen.  Clinical practice. Vitamin D insufficiency. , 2011, The New England journal of medicine.

[3]  E. Frohlich,et al.  Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy , 2011, Journal of hypertension.

[4]  M. Kiely,et al.  Vitamin D and cardiometabolic health: a review of the evidence , 2010, Nutrition Research Reviews.

[5]  H. Morris,et al.  Autocrine and paracrine actions of vitamin d. , 2010, The Clinical biochemist. Reviews.

[6]  L. Balluz,et al.  Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults , 2010, Journal of hypertension.

[7]  Gene Kim,et al.  Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. , 2010, The American journal of pathology.

[8]  M. D. Di Tullio,et al.  Cardiac structure and diastolic function in mild primary hyperparathyroidism. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  C. Camargo,et al.  Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). , 2010, The American journal of cardiology.

[10]  M. Ermani,et al.  Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[11]  A. Struthers,et al.  Effect of vitamin D on blood pressure: a systematic review and meta-analysis , 2009, Journal of hypertension.

[12]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[13]  S. Adami,et al.  25-hydroxy vitamin D levels in healthy premenopausal women: association with bone turnover markers and bone mineral density. , 2009, Bone.

[14]  S. Pilz,et al.  Vitamin D deficiency and myocardial dysfunction. , 2009, Journal of the American College of Cardiology.

[15]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[16]  Christopher S. Law,et al.  Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart , 2008, Hypertension.

[17]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[18]  J. Staessen,et al.  Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension. , 2007, American journal of hypertension.

[19]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.

[20]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[21]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[22]  J. Bernheim,et al.  Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. , 2007, American journal of physiology. Renal physiology.

[23]  D. Tishkoff,et al.  1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  R. Simpson,et al.  Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[26]  R. Schmieder.  The role of non-haemodynamic factors of the genesis of LVH. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  G. Sigurdsson,et al.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.

[28]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[29]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[30]  A. Ferguson,et al.  Cows' Milk Intolerance , 1988, Nutrition Research Reviews.

[31]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.